Kiniksa Pharmaceuticals International Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Private Companies | 8,078 | 0.0104% |
| Individual Insiders | 3,507,628 | 4.52% |
| VC/PE Firms | 7,429,639 | 9.57% |
| Hedge Funds | 31,789,285 | 40.9% |
| Institutions | 34,909,550 | 45% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 31,789,285 | US$586.5m | 0.44% | 7.03% | |||
| 7,429,639 | US$137.1m | 91.5% | 1.17% | |||
| 4,193,907 | US$77.4m | 31.9% | no data | |||
| 3,204,841 | US$59.1m | 11.2% | 5.52% | |||
| 2,981,894 | US$55.0m | 0.56% | no data | |||
| 2,196,009 | US$40.5m | -24.5% | 0.84% | |||
| 1,888,544 | US$34.8m | 22.2% | no data | |||
| 1,698,997 | US$31.3m | 0.62% | no data | |||
| 1,478,505 | US$27.3m | 0% | no data | |||
| 1,460,633 | US$26.9m | -7.01% | 0.02% | |||
| 1,392,716 | US$25.7m | 0% | 1.64% | |||
| 1,155,353 | US$21.3m | -23.5% | no data | |||
| 829,920 | US$15.3m | 103% | no data | |||
| 789,261 | US$14.6m | 0% | 0.86% | |||
| 725,511 | US$13.4m | 3.7% | no data | |||
| 666,976 | US$12.3m | -6.7% | 0.15% | |||
| 648,087 | US$12.0m | -10.3% | 0.45% | |||
| 646,163 | US$11.9m | 4.95% | 1.6% | |||
| 622,540 | US$11.5m | -5.92% | 0.08% | |||
| 618,798 | US$11.4m | -2.71% | 0.69% | |||
| 506,299 | US$9.3m | 44.8% | no data | |||
| 500,000 | US$9.2m | -16.7% | 1.2% | |||
| 456,041 | US$8.4m | 0% | 0.16% | |||
| 431,030 | US$8.0m | -22.7% | no data | |||
| 400,441 | US$7.4m | -12.2% | 3.69% |